Mounjaro®
Starting from £179.99/mo
Start journey Learn moreSome people notice their skin feels more reactive, tender or easily irritated after starting semaglutide. Sensitive skin on Wegovy is a real experience, though it is not listed among the most common side effects in the prescribing information. Here is what the clinical evidence actually shows, what is likely driving it, and when it is worth raising with your prescriber. Wegovy is a prescription-only medicine; a clinician must assess your suitability before treatment begins.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Picture this: you are a few weeks into Wegovy, the initial nausea has eased, and suddenly your skin feels oddly thin or tender to the touch. Clothing that never bothered you feels scratchy. Your face flushes more easily in the shower. You wonder whether the medicine is doing something strange to your skin.
The most likely explanation is not a direct drug effect on your skin cells but a downstream consequence of the gastrointestinal changes semaglutide causes. Reduced appetite means many people eat and drink less than usual in the first weeks. If fluid intake falls significantly, skin loses some of its normal resilience. Dry, under-hydrated skin is far more reactive to friction, temperature change and even gentle pressure. That can feel, from the inside, like sensitivity that appeared from nowhere.
The Wegovy treatment page has a broader overview of how semaglutide works, but the short version here is that GLP-1 receptor activation slows gastric emptying and reduces appetite, and both of those effects have knock-on consequences for how much fluid and nutrition you absorb day to day. Prioritising water intake during the adjustment phase is one of the most practical things you can do for your skin, and if you want a fuller picture of whether Wegovy can make your skin sensitive, that page brings together the evidence and the most common patient experiences. Aim to drink consistently throughout the day rather than compensating in large bursts.
According to the NHS medicines information for semaglutide, common side effects are overwhelmingly gastrointestinal: nausea, vomiting, constipation, diarrhoea and indigestion. Skin sensitivity as a standalone symptom is not highlighted in that list, which is worth knowing, it does not mean your experience is invalid, only that other mechanisms are likely at play.
Injection-site reactions are an acknowledged side effect of Wegovy: redness, swelling, bruising or a mild burning sensation at the injection spot. These are local responses to the needle and the formulation, not signs that your immune system is rejecting the medicine. They typically settle within a day or two.
Rotating your injection sites properly (abdomen, thigh or upper arm in turn) keeps any one area from becoming repeatedly sensitised. If you are noticing persistent soreness, tenderness that spreads beyond the injection site, or skin changes that last more than a couple of days, that is worth mentioning to your prescriber rather than waiting for a scheduled review.
One misconception worth addressing gently: some people worry that skin sensitivity means they are allergic to semaglutide. True allergic reactions to the medicine are rare, and when they occur they tend to present with more obvious signs, hives, swelling of the face or throat, difficulty breathing. Mild localised redness after an injection is not in that category. If you are unsure which you are dealing with, the practical test is simple: does the reaction stay local and fade quickly, or does it spread and intensify? The former can wait for a conversation; the latter needs urgent medical attention that day.
For a closer look at tactile sensitivity specifically, our page on skin sensitive to touch on semaglutide goes into more depth on the nerve-related theories.
A separate thread in the sensitive-skin conversation involves light. Some people on semaglutide report that their skin burns more quickly in sunlight or feels uncomfortably hot after modest sun exposure. This is not listed as a known pharmacological effect of semaglutide in its summary of product characteristics, but the pattern appears often enough in patient experience to be worth flagging here.
The most plausible explanation again circles back to hydration and nutritional status. Skin that is slightly depleted in moisture and certain micronutrients has less natural protection against UV radiation. Rapid weight loss itself, regardless of the method, can change skin thickness and composition. If you are spending time outdoors, a higher SPF than you might normally use is a sensible precaution rather than an excessive one. Our page on Wegovy and sun sensitivity covers this in more detail, including practical steps for protecting your skin through treatment.
It is also worth reading about light sensitivity on Wegovy if you notice that your eyes, not just your skin, feel more reactive to bright conditions, a small number of people on GLP-1 medicines report this too.
Most skin changes on Wegovy are mild, transient and manageable without any change to treatment. Staying hydrated, eating enough protein, using a gentle fragrance-free moisturiser and rotating injection sites will address the majority of cases.
Contact a clinician promptly if you notice: a widespread rash or hives; skin reactions accompanied by swelling of the face, lips or tongue; or any difficulty breathing alongside a skin change. These warrant same-day attention. For anything less acute, your next scheduled prescriber review is the right time to raise it, or you can reach the nume support team seven days a week if a concern comes up between reviews.
The MHRA's Yellow Card scheme lets you report any suspected side effects directly to the regulator, including skin reactions. Reporting matters: it helps the MHRA monitor the real-world safety profile of medicines like Wegovy and adds to the evidence base for everyone who follows.
If you are still in the early stages of deciding whether semaglutide treatment is right for you, our semaglutide information page covers the full clinical picture. You can also explore the weight-loss treatments page to check your eligibility and, if suitable, start a free consultation reviewed by a GPhC-registered prescriber. That is always a good starting point.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.